Jason Duncan joined Albireo in 2018 as Chief Legal Officer and General Counsel. Mr. Duncan has more than 15 years of legal and compliance experience in the pharmaceutical industry. He most recently served as General Counsel at Stallergenes Greer, where he oversaw all legal activities for the allergy immunotherapy company’s Americas business. Previously, Mr. Duncan was Vice President, Head of Compliance and Legal for Sobi, a global biopharmaceutical company focused on rare inflammatory and genetic diseases. At Sobi, he was responsible for all legal and compliance matters for the company’s North American affiliates and served on the leadership team. Prior to Sobi, Mr. Duncan held roles of increasing responsibility at EMD Serono, culminating in his position as Associate General Counsel for Neurology and Discovery.